HR Positive HER2 Negative Advanced Breast Cancer Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer
HR Positive HER2 Negative Advanced Breast Cancer
wanghaibo120 enrolled2 locationsNCT07285382
Recruiting
Not Applicable
A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy
HR Positive HER2 Negative Advanced Breast Cancer
Tianjin Medical University Cancer Institute and Hospital60 enrolled1 locationNCT05890287